Rellergen
Latest round
- Series A
Last raised
- Jan 2022
Total raised
- Undisclosed
Investors
- 3
About Rellergen
Established in 2016 and based in Xiamen, China, Rellergen is a biotechnology company that provides diagnostic solutions for allergy and autoimmune diseases. Rellergen is committed to providing diagnostic solutions for the diagnosis of allergies and autoimmune diseases based on the development, production and application promotion of microfluidic chip detection technology. The company established a high-performance and high-throughput technology platform that takes microfluidic technology as the core, combines technologies of protein coating and chemiluminescence detection. This platform aimed to provide more accurate and efficient detection solutions for clinical medicine and biological research. First application of the platform was to detection of allergen slgE. It only takes 100ul of serum samples to finish all 39 product testing procedures in clinical registration in 35 mintues. Rellergen is going to accelerate clinical registration, realize the localization of key materials and accelerate the development of new products and technology platforms.
Who invested in Rellergen
3 investors across 1 round
See all investors in Rellergen
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 10, 2022
Amount
Undisclosed
Investors
Questions about Rellergen
Who invested in Rellergen?
Rellergen has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Rellergen raised?
Rellergen has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Rellergen last raise money?
Rellergen's most recent round on record is a Series A, in Jan 2022.
What does Rellergen do?
Established in 2016 and based in Xiamen, China, Rellergen is a biotechnology company that provides diagnostic solutions for allergy and autoimmune diseases.
Where is Rellergen headquartered?
Rellergen is headquartered in Xiamen, China.
Which VCs invest in companies like Rellergen?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Rellergen's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Rellergen? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.